• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Jazz Pharmaceuticals

Jazz Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Implanet Announces Definitive Clinical Results in a Comparative Study of the JAZZ Band in Idiopathic Scoliosis Surgery

    Implanet Announces Definitive Clinical Results in a Comparative Study of the JAZZ Band in Idiopathic Scoliosis Surgery

  2. Kyle Bass's New Tack: Dispute the Patent, Short the Stock

    Kyle Bass's New Tack: Dispute the Patent, Short the Stock

  3. Should you quit Spotify for Tidal?

    Should you quit Spotify for Tidal?

  4. A Young Power Couple's Kickstart Portfolio

    With "massive" student debt loads receding in the rearview mirror, a young professional couple fires up their investment plan.

  5. Gross: Economy Can't Survive Much Higher Rates

    During his keynote presentation at the Morningstar Investment Conference, the PIMCO manager made the case that high debt levels and a need for financial stability mean that central banks should keep real rates close to zero for some time.

  6. Morningstar Indexes: Weekly Market Report

    Week ending Sept.29: Investors stay optimistic amid doom and gloom.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.